Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Wishing our readers a very Happy New Year 2022!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
The Strategy focus on values of universality, equity, solidarity and accountability and on the conviction that PHC services must be people-centred, resilient and adaptive, and informed by local knowledge. Evidence-driven, it also reflect the economic case for investing in PHC.
Dr Poonam Khetrapal Singh
Regional Director
WHO South East Asia
Sponsor
Patient Safety Capsules
Lack of awareness about generic drugs leading to rising healthcare costs among public: Experts
Hyderabad, December 23, 2021: Lack of awareness about the availability of generic medicines at the medical shops and pharmacies is forcing common public to spend more on branded medicines, because of which people are facing the brunt of increasing healthcare costs, opined pharmacy experts from Hyderabad.
Health ministry extends date of implementation of UDI for medical devices
New Delhi, December 28, 2021: The ministry of health and family welfare has decided to extend the date of implementation of the unique device identification (UDI) of medical devices, which was to come into effect from January 1, 2022, till further orders.
Drug Laws & Policy Injections
Government Commission recommends EUA for COVID-19 vaccines- Covovax, Corbevax and anti-Covid Pilmorne PyravirNew Delhi, December 28, 2021: An expert committee of the national central drug authority recommended granting an emergency use authorization to the COVID-19 vaccine Covovax and the Biological E vaccine Corbevax from the Indian Serum Institute under certain conditions.
2% of drug samples tested by CDSCO in November declared as not of standard quality New Delhi, December 23, 2021: Around two per cent of the total drug, medical devices and cosmetics products samples tested by the country’s drug regulator across various Central Drugs Laboratories in November, 2021, turned out to be not of standard. There were no spurious or misbranded drugs identified during the month, according to an update by the regulator.
Delhi HC seeks clarification from CCI & SEBI on PharmEasy’s acquisition of ThyrocareNew Delhi, December 28, 2021: The Delhi High Court has issued notice to the Competition Commission of India (CCI) and Securities and Exchange Board of India (SEBI) seeking clarification from them on denial of the South Chemists & Distributors Association (SCDA)’s objection to PharmEasy’s acquisition of Thyrocare, a chain of diagnostic and preventive care laboratories.
NITI Aayog announces state health indicators. Kerala tops, UP worstNew Delhi, December 27, 2021: Kerala remains the number one in overall health performance among the larger states in the State Health Index released by Niti Aayog on Monday. The fourth edition of SHI, 2019-20, “Healthy States, Progressive India,” ranked states and union territories by year-over-year incremental performance and overall status of health outcomes.
Centre to extend National Health Mission till 2025-26, reconstitutes EPCNew Delhi, December 30, 2021: The Central government may soon bring out a cabinet note extending the National Health Mission (NHM) for five more years, till 2026. The ministry of health and family welfare (MoHFW), in the wake of decision to extend the Mission, has reconstituted the Empowered Programme Committee (EPC), one of the highest policy marking and steering institutions under NHM.
DGCI nod to Covaxin for use in children above 12 years with certain conditionsNew Delhi, December 25, 2021: The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech’s Covaxin for children above 12 years with certain conditions, official said on Saturday.
Pharma Injections
Pharma industry in Madurai needs immediate survival measures, production and supply shrink every yearChennai, December 23, 2021: The pharmaceutical manufacturing units (MSMEs) in the southern districts of Tamil Nadu have sought more support from government and industrial side for consistent growth of the sector.
Delhi DC dept implements online national drugs licensing systemMumbai, December 24, 2021: The Delhi drugs control (DC) department has implemented the online national drugs licensing system (ONDLS) for online processing of various licenses issued by the department including manufacturing and sales licenses, good manufacturing practice (GMP) certificates, etc.
Omron Healthcare to foray into remote patient monitoring domain Mumbai, December 31, 2021: Omron Healthcare India, a global leader in digital blood pressure monitoring domain, aims to foray into remote patient monitoring domain via collaborations to help develop the right solutions in the preventive healthcare.
KMC to transform clinics into children’s jab units Kolkata, December 26, 2021: The Health Department of the Municipal Public Corporation of Kolkata is preparing to transform the primary health center in the city into a vaccination center for children aged 15-18. The same center is also used to administer booster immunity to health and frontline workers and the elderly with comorbidities.
KITES Senior Care plans to expand to South India National, December 22, 2021: KITES Senior Care, a brand specializing in geriatric medicine founded in Bangalore, today announced plans for expansion in southern India. This comes after a proven success in a pilot project to provide seniors with the finest geriatric care in both step-down care facilities and seniors’ homes.
Indian Pharma Market registers 6.6% growth in November 2021 Mumbai, December 28, 2021: The Indian Pharmaceutical Market (IPM) has registered a growth of 6.6 per cent for the month of Novem-ber 2021, after registering a growth of 5 per cent for the month of October 2021.
Drug Dopes
DST secretary calls on researchers to engage students in industrial research to drive scientific innovationHyderabad, December 27, 2021: Dr Srivari Chandrasekhar, secretary, Department of Science and Technology (DST), has called upon the lead re-searchers and scientists to engage students and youth in industrial research and project as a culture to drive scientific research innovation at the budding stage.
Imports of IVD reagents and consumable & disposable medical devices grow in 2020-21New Delhi, December 24, 2021: India’s imports of in vitro diagnostics (IVD) reagents and consumable & disposable medical devices lead the growth of medical devices imports during the year 2020-21, during when the Covid-19 pandemic has hit the markets across the world. The electronics equipment, surgical instruments and Implants imports were lower during the year compared to the 12 months of previous fiscal year.
Increasing penetration of sustainable packaging in the healthcare industry December 26, 2021: The Indian packaging industry is expected to grow at 26.7% (annual compound) over the next five years. The in-creased demand for packaging is primarily due to demand for food and other consumer products, hygiene, medical and pharmaceuticals. It is one of the fastest growing sectors in the country. More than 49% of domestically produced paper is used for packaging.
Omicron jeopardizes corporate recovery New Delhi, December 27, 2021: Hospitals and diagnostics companies have grown so much that companies have returned to pre-COVID levels. A recently released Healthcare Outlook 2022 study by ICICI Securities expects long-term growth and a healthy recov-ery in the non-COVID segment of healthcare services, improving potential margins through changes in cost man-agement initiatives and mixes. Will lead to.
RAT, Recommended for Surveillance to Check Omicron Spread and Spikes PUNE, December 27, 2021: Syndrome surveillance to increase the use of Rapid Antigen Test (RAT) over RT-PCR in addition to genomic se-quencing of Covid-19-positive samples to rapidly isolate and treat symptomatic individuals. With regular implementation, you can check for spikes without harsh rim stones.
Gap between 2nd Covid vaccine shot and precaution dose likely to be 9-12 monthsDecember 26, 2021: The gap between the second dose of COVID-19 vaccine and the third, which is being called a “precaution dose”, is likely to be nine to 12 months, official sources said on Sunday.
National Injections
Third Covid wave in India may peak in early Feb: IIT-Kanpur study December 25, 2021: The third wave of the COVID-19 pandemic in India may peak by February 3, 2022, claims a modelling study by researchers at Indian Institute of Technology Kanpur.
TN PMA urges state govt to modify public procurement norms to give price preference to local companiesChennai, December 29, 2021: The micro, small and medium pharma enterprises (MSMEs) in Tamil Nadu have appealed to the state government to modify the norms of public procurement for pharmaceutical products with maximum preference to the domestic manufacturers with an aim to make the state self-reliant in drug production.
India approves two vaccines and one drug against Covid-19 in single day New Delhi, December 29, 2021: In a rare feat in the nation's drug approval history, the Central Drugs Standard Control Organisation (CDSCO) has provided approval to three Covid-19 related drugs in a single day.
Assam School for Children to Turn into a Jab Center GUWAHATI, December 28, 2021: Public and private schools with about 100 to 200 students are Assam’s children as the State Health Department prepares to vaccinate children between the ages of 15 and 18 from January 3rd. It will be a Covid vaccination center for.
Domestic pharmaceutical companies are preparing for the launch of Merck’s Covid pills December 29, 2021: Molnupiravir, the first Covid-19 antiviral drug to receive an Emergency Use Authorization (EUA) on Tuesday, will hit the market in a week or two as more than 12 Indian pharmaceutical companies compete for drug launches. It will be released.
Delhi Police revises SOP on health welfare for personnel amid Omicron threat New Delhi, December 29, 2021: Amid a rise in the number of coronavirus cases and that of its new variant Omicron, the Delhi Police has revised the standard operating procedure on health welfare for its personnel, stating that an officer of the rank of inspector and above should personally visit the hospitalised personnel or their kin on a regular basis, according to an official statement issued on Wednesday.
Global Injections
CDC Shortens COVID Isolation, Quarantine TimesDecember 28, 2021: The CDC recommended shorter COVID-19 isolation and quarantine periods on Monday, cutting the time for people without symptoms and close contacts from 10 days to 5 days.
U.S. Army Developing Its Own COVID-19 VaccineDecember 23, 2021: The U.S. Army is conducting clinical trials on a vaccine designed to be effective against COVID-19 and its variants, the website Defense One reported.
France tightens restrictions amid Omicron surge
December 27, 2021: From 3 January, remote working will become compulsory for those who can and public gatherings will be limited to 2,000 people for indoor events.
Half of colds will be Covid, warn UK researchers
December 23, 2021: The Zoe Covid study team has been tracking the pandemic using feedback from the general public, and estimates half of people with cold-like symptoms actually have Covid.
Can the FDA whittle down its manufacturing site inspection backlog next year?
December 22, 2021: Over the course of 2021, lawmakers, government officials and the FDA's top brass have wracked their brains for a solution to the agency's hefty drug manufacturing inspection backlog. The regulator has started to right the ship at home, but abroad, problems persist.
Girding for BMS competition, Amgen wins another plaque psoriasis nod for Otezla
December 21, 2021: On Monday, Otezla nabbed an FDA approval that expands its use to those who are candidates for phototherapy or systemic therapy. The indication, for the milder version of the disorder, now makes Otezla the only oral treatment sanctioned all severities of plaque psoriasis—mild, moderate and severe. It also brings roughly 1.5 million potential patients into the fold.
PSAIIF PILL
Insurance companies cannot reject medical claims by citing existing conditions
New Delhi, December 28, 2021: Insurance companies cannot deny claims by citing existing medical conditions disclosed by the insured in the pro-posal after the insurance contract has been issued, the Supreme Court said. rice field.
Researchers find alternative methodology to chemo and radiation therapy for treating cancer
Hyderabad, December 29, 2021: Indian researcher from Allahabad along with a team of scientists from USA based Cleaveland Clinic have discovered a new way to treat cancer tumors and do away with the existing chemo and radiation therapy to kill the cancer cells.
Frequently Asked Questions
Why India is administering ‘precautionary’ shots and who are qualified for it?
Prime Minister Narendra Modi recently announced the third dose of Covid-19 vaccine for healthcare and frontline workers and ‘precautionary dose’ for those above the age of 60 years. As the second kind starts administering on January 10 beneficiaries above the age of 60 years with associated comorbidities and those who got their second vaccine dose nine months ago are qualified for the same.
SUBSCRIBER'S SYMPTOM
Covid-19: Lessons from 2021 & what to expect in 2022
December 29, 2021: The year 2021 may go down as one of the most painful years in recent memory for India. From languid, weak and financially drained family members scurrying around for hospital beds to embittered young minds bearing the brunt of a strained and stretched healthcare lattice, it was all along a story of sorrow unfolding.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Mr Prem Burman, Professional Excellent articles being published every edition. Very enjoyable..
Ms Gauri Singh, Pharma expertIndeed a pleasure to receive the newsletter and read it. Well done.
Mr Santosh Nag, MBBS
Presented very beautifully and aptly captures important developments in the Pharma space.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
